Identification of a mutation in the promoter region of the dystrophin gene in a patient with atypical Becker muscular dystrophy

Hum Genet. 1991 Dec;88(2):195-9. doi: 10.1007/BF00206071.


We have identified 7 patients with Becker muscular dystrophy (BMD) in whom analysis of dystrophin by immunoblotting shows a full-sized molecule produced at reduced abundance compared with controls. They have no detectable deletion in their dystrophin cDNA. One patient presented atypically with unusually severe cramps as his only symptom for 25 years. These patients were investigated using the polymerase chain reaction (PCR) with 3 sets of primers within the promoter region of the dystrophin gene, followed by dot blot and restriction analysis. In the patient with the atypical history, one of the expected fragments on PCR failed to amplify. A large deletion was excluded by the finding of normally sized fragments on amplification with the other primer sets. The mutation was localised to the 3' end of the forward primer binding site by dot blot and restriction analysis. This result supports the hypothesis that, in patients with a full-sized dystrophin molecule produced at reduced abundance, the phenotype may result from a mutation in the promoter region of the dystrophin gene. The atypical history of the patient in whom this was detected adds to the variety of phenotypes now known to exist as BMD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Base Sequence
  • Child
  • Chromosome Deletion
  • Dystrophin / analysis
  • Dystrophin / genetics*
  • Exons / genetics
  • Genetic Linkage / genetics
  • Humans
  • Immunoblotting
  • Middle Aged
  • Molecular Sequence Data
  • Muscular Dystrophies / genetics*
  • Mutation / genetics
  • Polymerase Chain Reaction
  • Promoter Regions, Genetic / genetics*
  • X Chromosome


  • Dystrophin